MMP9 and neurodegenerative disease: The present review synthesizes current evidence on how clinically approved drugs and investigational agents modulate MMP-9 expression and activity, aiming to point out therapeutic opportunities for state-specific regulation across inflammatory, fibrotic, vascular, and neurodegenerative diseases.